Talk:Michelle Dipp

This is the talk page for discussing improvements to the Michelle Dipp article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.

If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.

Biography

This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography articles

Women in Business Low‑importance

	This article is within the scope of WikiProject Women in Business, a collaborative effort to improve the coverage of articles about women in business on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Women in BusinessWikipedia:WikiProject Women in BusinessTemplate:WikiProject Women in BusinessWomen in Business articles
Low	This article has been rated as Low-importance on the project's importance scale.

The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.

RGReiber (talk · contribs) This user has declared a connection.

Update Requests[edit]

Some small suggested changes

1. As of 2017, she was co-founder and executive chairwoman of OvaScience, an In vitro fertilisation company; co-founder and partner of Longwood Fund, a healthcare venture capital firm; and Chairman of the Board of Axial Biotheraputics, a biotech company using bacteria to treat neurological disorders.^[1], ^[2] Dipp also co-founded Longwood portfolio companies Alnara Pharmaceuticals^[3] (acquired by Eli Lilly),^[4] Verastem (NASDAQ: VSTM),^[5], and FlexPharma (NASDAQ: FLKS).^[6]

2. Dipp was raised in El Paso, Texas and earned her MD and PhD from the University of Oxford, with a dissertation on pulmonary hypertension.^[7]

Requested additions

1. Dipp serves on the Biotechnology Industry Organization's (BIO) Emerging Companies Governing Board, the New England Venture Capital Association (NEVCA) Board, the Beth Israel Deaconess Medical Center Board, and the Boston Symphony Orchestra Board of Overseers.

2. In 2015, Dipp was elected to the World Economic Forum's Young Global Leaders and made Fortune magazine's 40 Under 40 list.^[8]^[9] Dipp is the women's health contributor for Arianna Huffington's Thrive Global.

3. June 30, 2020 - The Securities and Exchange Commission announced that Michelle Dipp, a co-founder and former CEO of the now defunct OvaScience, Inc., agreed to settle fraud charges for misleading investors about the availability and commercial prospects for the company’s fertility treatments that were in development ^[10]

References

RGReiber (talk) 13:42, 18 May 2017 (UTC) Updated: RGReiber (talk) 12:15, 25 May 2017 (UTC)[reply]

Thanks for the additional content and refs. The refs do not support Dipp as co-founder of Verastem (ref says Longwood made the founding investment and participated in Series A) nor of Flex (ref says was founded by Westphal, MacKinnon, Bean, and Cermak, and that Dipp and some others were "involved" as advisors... I had already added Axial. Will add the dissertation topic and the various seats as supported by refs Jytdog (talk) 15:39, 25 May 2017 (UTC)[reply]

I meant to ask, it would be great to have refs for when she started those various seats (BIO, etc). Can you provide refs for them? thx Jytdog (talk) 15:42, 25 May 2017 (UTC)[reply]

Actually I have dealt with all the company stuff. Just the board stuff (BIO, BSO, etc) is left. Jytdog (talk) 17:44, 25 May 2017 (UTC)[reply]

Here's what I could find: BIO,^[1] NEVCA,^[2] BIDMCB,^[3], BSO^[4] -- her name is on the list of overseers but no real details.

References

--RGReiber (talk) 12:03, 26 May 2017 (UTC)[reply]

Are these OK sources? RGReiber (talk) 17:32, 31 May 2017 (UTC)[reply]

Thanks. For this kind of thing press releases are actually Ok. Jytdog (talk) 03:13, 1 June 2017 (UTC)[reply]

Oh perfect, thanks again! RGReiber (talk) 12:13, 1 June 2017 (UTC)[reply]

UPE[edit]

The article seems to have had undisclosed paid editors adding to the article for a long time. I'm adding and leaving a maintenance tag up until others can check over the article for neutrality.

I've already started to remove unreliable sources and info that isn't currently sourced, but it needs more work, especially checking 2008 and onward in the career section. - Whisperjanes (talk) 10:07, 26 November 2021 (UTC)[reply]

[1] ttp://www.bizjournals.com/boston/news/2016/11/30/this-new-boston-biotech-has-a-gut-feeling-about.html

[2] ttp://www.xconomy.com/boston/2016/11/30/with-19m-axial-becomes-latest-startup-to-target-gut-brain-connection/

[3] ttp://www.xconomy.com/boston/2010/04/22/sirtris-vet-michelle-dipp-takes-over-key-role-at-glaxo-as-westphal-returns-to-vc/2/

[4] ttp://www.xconomy.com/boston/2010/07/20/eli-lilly-pays-up-to-380m-for-alnara-pharma/

[5] ttp://www.xconomy.com/boston/2010/11/16/verastem-led-by-mit-big-names-raises-16m-to-fight-cancer-stem-cells/

[6] ttp://www.xconomy.com/boston/2015/01/28/investors-line-up-for-westphal-as-muscle-cramp-startup-upsizes-ipo/

[7] ttps://www.bostonglobe.com/business/2012/10/13/michelle-dipp-ovascience-leading-new-generation-biotech-ceo/VqbVwXvcQSRkIVCQapdjhI/story.html

[8] ttps://www.weforum.org/agenda/2015/03/meet-the-2015-class-of-young-global-leaders/

[9] ttp://fortune.com/40-under-40/2015/michelle-dipp-28/

[10] ttps://www.sec.gov/enforce/33-10794-s

[11] ttp://www.biospace.com/News/ovascience-ceo-michelle-dipp-m-d-ph-d-joins/318035

[12] ttp://www.newenglandvc.org/the-nevca-board/

[13] ttp://www.bidmc.org/News/PRLandingPage/2014/October/Board-of-Directors.aspx

[14] ttp://bso.http.internapcdn.net/bso/images/dev/BSO_15-16_Annual-Report_FY17-LowRes.pdf

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[1]

[2]

[3]

[4]